Antibacterial activity and cytotoxicity analysis of halistanol trisulphate from marine sponge Petromica citrina

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 10, 2012, Pages 2396-2400

  Marinho, Palloma R ^a   Simas, Naomi Kato ^a   Kuster, Ricardo Machado ^a   Duarte, Rafael Silva ^a   Fracalanzza, Sergio Eduardo Longo ^a   Ferreira, Davis Fernandes ^a   Romanos, Maria Teresa Villela ^a   Muricy, Guilherme ^a   Giambiagi Demarval, Marcia ^a   Laport, Marinella Silva ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antibiotic resistant bacteria; Bioactive substance; Porifera; Staphylococcus; Sulphated sterol

Indexed keywords

ANTIINFECTIVE AGENT; BENOMYL; HALISTANOL TRISULFATE; PETROMICA CITRINA EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOASSAY; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL DAMAGE; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG ISOLATION; ENTEROCOCCUS FAECALIS; FIBROSARCOMA; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM FORTUITUM; NEISSERIA GONORRHOEAE; PETROMICA CITRINA; PROTON NUCLEAR MAGNETIC RESONANCE; SPONGE (PORIFERA); STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL EXTRACTS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMICAL FRACTIONATION; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; PORIFERA; STEROLS;

EID: 84866628631     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks229     Document Type: Article

References (25)

1. Rice LB. Antimicrobial resistance in Gram-positive bacteria. Am J Infect Control 2006; 34 Suppl 1: S11-9.
2. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010; 74: 417-33.
3. White AR. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control. J Antimicrob Chemother 2011; 66: 1948-53.
4. Laport MS, Santos OCS, Muricy G. Marine sponges: potential sources of new antimicrobial drugs. Curr Pharm Biotechnol 2009; 10: 86-105.
5. Marinho PR, Muricy GRS, Silva MFL et al. Antibiotic-resistant bacteria inhibited by extracts and fractions from Brazilian marine sponges. Rev Bras Farmacogn 2010; 20: 267-75.
6. Laport MS, Marinho PR, Santo OCS et al. Antimicrobial activity of marine sponges against coagulase-negative staphylococci isolated from bovine mastitis. Vet Microbiol 2012; 155: 362-8.
7. Sahm DF, Kissinger J, Gilmore MS et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1989; 33: 1588-91.
8. Ferreira NAP, Martins TL, Reis BCC et al. Susceptibility of Brazilian staphylococcal strains to glycopeptides evaluated by different testing methods. Curr Microbiol 2002; 44: 385-90.
9. Duarte RS, Lourenço MC, Fonseca LS et al. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol 2009; 47: 2149-55.
10. Uehara AA, Amorin ELT, Ferreira M de F et al. Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil. J Clin Microbiol 2011; 49: 4208-12.
11. Yamada S, Sugai M, Komatsuzawa H et al. An autolysin ring associated with cell separation of Staphylococcus aureus. J Bacteriol 1996; 178: 1565-71.
12. Rahalison L, Hamburger M, Monod M et al. Antifungal tests in phytochemical investigations: comparison of bioautographic methods using phytopathogenic and human pathogenic fungi. Planta Med 1994; 60: 41-4.
13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
14. Isenberg HD. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology, 1992.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
16. DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 2009; 119: 2464-74.
17. Freitas D, Alvarenga L, Sampaio J et al. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 2003; 110: 276-85.
18. Padoveze MC, Fortaleza CM, Freire MP et al. Outbreak of surgical infection caused by non-tuberculous mycobacteria in breast implants in Brazil. J Hosp Infect 2007; 67: 161-7.
19. CDC. Sexually transmitted diseases treatment guidelines. Morb Mortal Wkly Rep 2002; 51: 36-7.
20. Fusetani N, Matsunaga S, Konosu S. Bioactive marine metabolites. II. Halistanol sulfate, an antimicrobial novel steroid sulfate from sponge Halichondria cf. moorei Bergquist. Tetrahedron Lett 1981; 21: 1985-8.
21. Yang JH, Suh SJ, Lu Y et al. Anti-inflammatory activity of ethylacetate fraction of Cliona celata. Immunopharmacol Immunotoxicol 2010; 33: 373-9.
22. Kanazawa S, Fusetani N, Matsunaga S. Bioactive marine metabolites. 42. Halistanol sulfates A-E, new steroid sulfates from a marine sponge Epipolasis sp. Tetrahedron 1992; 48: 5467-72.
23. Kossuga MH, Lira SP, Nascimento AM et al. Isolamento e atividades biológicas de produtos naturais das esponjas Monanchora arbuscula, Aplysina sp., Petromica ciocalyptoides e Topsentia ophiraphidites, da ascídia Didemnum ligulum e do octocoral Carijoa riisei. Quím Nova 2007; 30: 1194-202.
24. Sperry S, Crews P. Haliclostanone sulfate and halistanol sulfate from an Indo-Pacific Haliclona sponge. J Nat Prod 1997; 60: 29-32.
25. Das P, Mukherjee S, Sivapathasekaran C et al. Microbial surfactants of marine origin: potentials and prospects. Adv Exp Med Biol 2010; 672: 88-101.